Diets

ketogenic diet decreases seizure frequency in drug-resistant epilepsy

In plain terms: Does the ketogenic diet cut seizure frequency in drug-resistant epilepsy?

Strong support Diets

RefutedContestedStrong support

consensus score 0.93

Yes — this is its original, best-evidenced medical use: dietary therapy meaningfully reduces seizures, most robustly in children, with adult/RCT data thinner.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

17 support 0 contradict 0 tested null 3 mixed · 20 sources, 17 independent groups

Cochrane agrees with us see how our grade compares ▾

Cochrane review 2020 · see review (limited studies, small samples) Agrees with our grade

Effectiveness supported in CHILDREN; evidence in adults remains uncertain. Small studies, risk of bias and imprecision.

“Ketogenic diets for drug-resistant epilepsy (CD001903.pub5). 'The evidence suggests that KDs could demonstrate effectiveness in children with drug-resistant epilepsy, however, the evidence for the use of KDs in adults remains uncertain.'”

Why we agree: we reached the same direction independently, from our own appraisal of 20 sources. Two methods landing in the same place is a stronger signal than either alone.

What is Cochrane, and why trust it?

Cochrane produces systematic reviews: instead of running a new study, they gather every trial ever done on a question, judge how well each was run, and pool the results. They take no commercial or industry funding, which is why the medical community treats their reviews as a gold standard — and why we check our own verdicts against theirs.

About Cochrane ↗ · Get involved / support ↗

Read the Cochrane review ↗

The evidence (20)

Source	Grade	Stance	Quality	Finding
Kverneland 2018 · Epilepsia	RCT	mixed	moderate	RCT of modified Atkins diet in adults with drug-resistant focal epilepsy found only a modest, non-significant seizure reduction versus habitual diet.
Devi 2023 · JAMA Pediatrics	meta-analysis	supports	high	Network meta-analysis of childhood DRE dietary therapies found classical KD and variants significantly increased seizure-reduction and seizure-freedom odds.
Hahn W et al 2026 · study_type: RCT	RCT	mixed	moderate	Crossover pilot, n=22 completers; 9% seizure-free on IF-MCT; >=50% responder rate numerically higher vs IF-alone but not significant (Breslow p=.233)
Manral 2023 · Neurology	RCT	supports	high	RCT in adolescents/adults found modified Atkins diet plus standard therapy reduced seizure frequency more than standard therapy alone at 6 months.
Vaccarezza MM et al 2026 · study_type: meta-analysis	meta-analysis	supports	moderate	SR/MA of 17 RCTs: peds 37% achieve >=50% seizure reduction (moderate-certainty); adults/adolescents +16 more per 100 vs usual care (moderate-certainty)
Zhu 2025 · Epilepsy Behav	meta-analysis	supports	moderate	Network meta-analysis of RCTs of carbohydrate-restricted diets for drug-resistant epilepsy; efficacy well-established in pediatric populations, adult data underexplored.
Farrar 2026 · Seizure	meta-analysis	supports	high	Systematic review/meta-analysis of 33 studies (1019 adolescents/adults with DRE) found 42.8% achieved over 50% seizure reduction on ketogenic diet therapy.
Yavuz M et al 2026 · study_type: observational	observational	supports	low	Retrospective n=36 infants <2yo: ITT responder rates 52.8% (1mo) declining to 36.1% at 24mo; one-third seizure-free at 24mo among continuers
Chavez-Castillo M et al 2026 · study_type: observational	observational	supports	low	Retrospective n=20 peds: 10/20 (50%) achieved >=50% reduction and 4/20 (20%) >=90% at ~3mo; 9/14 (64%) >=90% by 3rd visit
Sharaf MA et al 2026 · study_type: meta-analysis	meta-analysis	supports	moderate	8-study MA: classic KD superior to modified Atkins for >=50% seizure reduction (OR=0.55, 95% CI 0.35-0.87, p=0.01); no diff for seizure freedom/>=90%
Meng X et al 2026 · study_type: meta-analysis	observational	mixed	low	SR of 8 non-standard-diet studies (n=675): olive-oil KD uncontrolled responder rate 83.1%; low-glutamate RCT showed no significant reduction (p=0.57)
Mustafa 2024 · Irish J Med Sci	meta-analysis	supports	high	Pooled 11 RCTs (788 children) showed ketogenic interventions raised odds of over 50% seizure reduction (OR 6.68) and seizure freedom (OR 4.13).
Dressler 2025 · Nutrients	observational	supports	moderate	Ketogenic diet therapy as second-line treatment in drug-resistant infantile epileptic spasms syndrome showed clinically useful seizure control.
Liu 2025 · Front Nutr	meta-analysis	supports	moderate	Meta-analysis in children with drug-resistant epilepsy found the high-fat low-carbohydrate ketogenic diet significantly reduced seizure frequency.
Matairi 2025 · World J Pediatr	meta-analysis	supports	moderate	Systematic review/meta-analysis of KD, modified Atkins, and low-glycemic-index therapy in drug-resistant epilepsy found significant reductions in seizure frequency across dietary therapies.
Ruan 2022 · Eur J Clin Nutr	meta-analysis	supports	moderate	Umbrella review of 24 systematic reviews reported consistent positive effects of ketogenic diet therapy on seizure-frequency reduction across epilepsy types.
Ray 2024 · Epilepsy Res	RCT	supports	moderate	Randomized study in pediatric refractory epilepsy: both classical and PUFA ketogenic diets reduced seizure frequency over 12 months, with responders reaching 50-90% reduction.
Han R et al 2026 · study_type: observational	observational	supports	moderate	Prospective cohort n=136 (73 KD/63 controls): KD arm showed higher proportion achieving >=50% seizure reduction at 6mo vs controls (no exact % given)
Feng Y et al 2025 · study_type: meta-analysis	meta-analysis	supports	moderate	Umbrella review of 18 MAs: dietary therapies (esp. LGIT) increased >=50% reduction RR=1.95 (95% CI 1.58-2.33) and >=90% RR=3.33 (1.51-5.14); no effect on seizure freedom
Martin-McGill 2020 · Cochrane Database Syst Rev	meta-analysis	supports	high	Cochrane review found ketogenic diets show promising short-term seizure-reduction rates in drug-resistant epilepsy, mainly from pediatric RCTs.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.